These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 37652695

  • 1. Bilateral Acute Iris Transillumination Associated with Moxifloxacin Antibiotic Use.
    Gorbea Fuxench GA, Ayala Rodríguez SC, Guardiola G, Ramos F, Pappaterra-Rodríguez M, Requejo Figueroa GA, Llop SM, Santiago LA, Santos C, Oliver AL.
    Ocul Immunol Inflamm; 2024 Sep; 32(7):1368-1373. PubMed ID: 37652695
    [Abstract] [Full Text] [Related]

  • 2. [Moxiflaxin and iris transillumination].
    Broens A, Collignon N.
    Rev Med Liege; 2016 Jul; 71(7-8):321-323. PubMed ID: 28383838
    [Abstract] [Full Text] [Related]

  • 3. Bilateral acute depigmentation of the iris (BADI) and bilateral acute iris transillumination (BAIT): A case series from a center in Brazil.
    Costa FV, Silva AGE, Pedroso LA, Biancardi AL, Curi ALL.
    Arq Bras Oftalmol; 2024 Jul; 87(4):e2023. PubMed ID: 38656031
    [Abstract] [Full Text] [Related]

  • 4. Bilateral Acute Iris Transillumination (BAIT): A Rare Syndrome Possibly Associated with COVID-19 and Moxifloxacin Use. A Report of 2 Cases.
    Lončarić K, Tadić R, Radmilović M, Vatavuk Z.
    Semin Ophthalmol; 2023 Apr; 38(3):312-315. PubMed ID: 36653737
    [Abstract] [Full Text] [Related]

  • 5. Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)-An Update.
    Tuğal-Tutkun İ, Altan Ç.
    Turk J Ophthalmol; 2022 Oct 28; 52(5):342-347. PubMed ID: 36317812
    [Abstract] [Full Text] [Related]

  • 6. [Moxifloxacin and iris transillumination].
    Broens A, Collignon N.
    Rev Med Liege; 2015 Dec 28; 70(12):606-8. PubMed ID: 26867304
    [Abstract] [Full Text] [Related]

  • 7. Severe sequelae in bilateral acute iris transillumination syndrome secondary to the use of oral moxifloxacin: a case report.
    Rivera-Valdivia N, Arteaga-Rivera K, Reyes-Guanes J, Neira-Segura N, de-la-Torre A.
    J Med Case Rep; 2021 Sep 19; 15(1):462. PubMed ID: 34537056
    [Abstract] [Full Text] [Related]

  • 8. Bilateral acute iris transillumination following systemic administration of antibiotics.
    Tranos P, Lokovitis E, Masselos S, Kozeis N, Triantafylla M, Markomichelakis N.
    Eye (Lond); 2018 Jul 19; 32(7):1190-1196. PubMed ID: 29497133
    [Abstract] [Full Text] [Related]

  • 9. Unilateral acute iris transillumination like syndrome following intracameral moxifloxacin injection.
    Zubicoa A, Echeverria-Palacios M, Mozo Cuadrado M, Compains Silva E.
    Ocul Immunol Inflamm; 2022 Feb 17; 30(2):318-319. PubMed ID: 32976059
    [Abstract] [Full Text] [Related]

  • 10. Bilateral Acute Depigmentation of Iris (BADI) and Bilateral Acute Iris Transillumination (BAIT)Following Acute COVID-19 Infection.
    Altan C, Basarir B, Bayraktar S, Tugal-Tutkun I.
    Ocul Immunol Inflamm; 2023 Aug 17; 31(6):1163-1168. PubMed ID: 36083696
    [Abstract] [Full Text] [Related]

  • 11. Bilateral Acute Iris Transillumination Syndrome Following Oral Moxifloxacin Overdose.
    Mendez Bermudez IJ, Ramirez Marquez E, Ayala Rodríguez SC, Ruiz-Justiz AJ, Rodriguez-Garcia EJ, Gonzalez M, Nieves I, Blasini M, Santos C, Oliver AL.
    Cureus; 2023 Oct 17; 15(10):e47426. PubMed ID: 38022122
    [Abstract] [Full Text] [Related]

  • 12. [Unusual anisocoria].
    Klonner J, Salchow D.
    Ophthalmologe; 2021 Jun 17; 118(6):597-599. PubMed ID: 32588124
    [Abstract] [Full Text] [Related]

  • 13. Bilateral acute iris transillumination syndrome. A case report.
    Plaza-Ramos P, Heras-Mulero H, Fanlo P, Zubicoa A.
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Sep 17; 93(9):447-450. PubMed ID: 29398234
    [Abstract] [Full Text] [Related]

  • 14. Bilateral acute iris transillumination (BAIT) syndrome: Differential diagnosis based on clinical, OCT and UBM findings.
    Cronemberger S, Vasconcelos-Santos DV, Correia de Carvalho C, Carvalho JH, Calixto J, Diniz-Filho A.
    Eur J Ophthalmol; 2024 Jan 17; 34(1):NP22-NP26. PubMed ID: 37160763
    [Abstract] [Full Text] [Related]

  • 15. Bilateral acute iris transillumination syndrome following COVID-19 infection and moxifloxacin use.
    Lazari K, Androudi S, Dardiotis E, Tsironi EE, Papageorgiou E.
    Clin Exp Optom; 2024 Sep 17; 107(7):764-766. PubMed ID: 37674269
    [No Abstract] [Full Text] [Related]

  • 16. Unilateral Acute Iris Transillumination Syndrome following Uneventful Phacoemulsification Surgery with Intracameral Moxifloxacin.
    Gonul S, Eker S.
    Ocul Immunol Inflamm; 2022 Sep 17; 30(7-8):1984-1987. PubMed ID: 34003710
    [Abstract] [Full Text] [Related]

  • 17. Bilateral acute Iris transillumination after COVID-19 pneumonia.
    Yüksel M, Özdemir HB, Özdek Ş, Gürelik G.
    Eur J Ophthalmol; 2023 Jul 17; 33(4):NP115-NP118. PubMed ID: 35850544
    [Abstract] [Full Text] [Related]

  • 18. Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.
    Gonul S, Bakbak B.
    Ocul Immunol Inflamm; 2022 Jan 02; 30(1):244-245. PubMed ID: 32946301
    [Abstract] [Full Text] [Related]

  • 19. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin.
    Wefers Bettink-Remeijer M, Brouwers K, van Langenhove L, De Waard PW, Missotten TO, Martinez Ciriano JP, Van Aken E.
    Eye (Lond); 2009 Dec 02; 23(12):2260-2. PubMed ID: 19851342
    [Abstract] [Full Text] [Related]

  • 20. Acute depigmentation of the iris: a retrospective analysis of 22 cases.
    Kawali A, Mahendradas P, Shetty R.
    Can J Ophthalmol; 2019 Feb 02; 54(1):33-39. PubMed ID: 30851772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.